Covered recipient · General Payments record
ALEX AGELIDIS
General Payments · PY2023–2024
$779.10
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.40 | 11 |
| Education | $155.19 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $134.42 | 2 |
| SOBI, INC | $101.37 | 3 |
| Incyte Corporation | $95.00 | 1 |
| Lilly USA, LLC | $60.19 | 1 |
| GlaxoSmithKline, LLC. | $34.41 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.65 | 1 |
| BeiGene USA, Inc. | $26.83 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.94 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $15.82 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $21.94 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086108058 | CMS |
| BeiGene USA, Inc. | $26.83 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120852332 | CMS |
| E.R. Squibb & Sons, L.L.C. | $114.98 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101546884 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.44 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101546875 | CMS |
| GlaxoSmithKline, LLC. | $34.41 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116069838 | CMS |
| Incyte Corporation | $95.00 | 05/24/2024 | Education | Undisputed | 01/23/2026 | 1141192415 | CMS |
| Lilly USA, LLC | $60.19 | 01/19/2024 | Education | Undisputed | 01/23/2026 | 1136017173 | CMS |
| PROGENICS PHARMACEUTICALS, INC. | $15.82 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128510905 | CMS |
| SERVIER PHARMACEUTICALS LLC | $14.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147257860 | CMS |
| SOBI, INC | $41.25 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141416248 | CMS |
| SOBI, INC | $34.22 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141422301 | CMS |
| SOBI, INC | $25.90 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141440353 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.65 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144952127 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.